Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
2.400
-0.050 (-2.04%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Silo Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 0.05 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| 0.05 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | |
Revenue Growth | -25.00% | 0% | 0% | 0% | 1.18% | - |
Cost of Revenue | 0.06 | 0.04 | 0.01 | 0.01 | 0.01 | 0.01 |
Gross Profit | -0.01 | 0.03 | 0.07 | 0.07 | 0.07 | 0.07 |
Selling, General & Admin | 2.29 | 2.15 | 2.4 | 3.08 | 2.43 | 2.27 |
Research & Development | 2.16 | 2.16 | 2.37 | 0.85 | 1.29 | 0.69 |
Operating Expenses | 4.45 | 4.31 | 4.77 | 3.92 | 3.71 | 2.96 |
Operating Income | -4.46 | -4.28 | -4.71 | -3.86 | -3.65 | -2.89 |
Interest Expense | -0.04 | -0.04 | -0.01 | -0 | -0 | -0 |
Interest & Investment Income | 0.17 | 0.19 | 0.33 | 0.4 | 0.07 | 0 |
Currency Exchange Gain (Loss) | -0 | - | -0.01 | - | - | - |
Other Non Operating Income (Expenses) | -0.22 | -0.1 | - | - | - | - |
EBT Excluding Unusual Items | -4.56 | -4.23 | -4.39 | -3.46 | -3.58 | -2.89 |
Gain (Loss) on Sale of Investments | 0 | 0 | -0 | -0 | -0.44 | 6.91 |
Other Unusual Items | 0.09 | - | - | -0.17 | 0.11 | 0.17 |
Pretax Income | -4.47 | -4.23 | -4.39 | -3.63 | -3.91 | 4.18 |
Income Tax Expense | - | - | - | - | - | 0.02 |
Earnings From Continuing Operations | -4.47 | -4.23 | -4.39 | -3.63 | -3.91 | 4.16 |
Earnings From Discontinued Operations | - | - | - | -0.07 | -0 | -0.25 |
Net Income | -4.47 | -4.23 | -4.39 | -3.7 | -3.91 | 3.9 |
Preferred Dividends & Other Adjustments | - | - | - | - | - | 1.4 |
Net Income to Common | -4.47 | -4.23 | -4.39 | -3.7 | -3.91 | 2.5 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1 | 1 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 1 | 1 | 0 | 0 | 0 | 0 |
Shares Change | 170.50% | 127.75% | 19.50% | 34.83% | 19.07% | 45.44% |
EPS (Basic) | -5.07 | -7.57 | -17.90 | -18.02 | -25.67 | 19.76 |
EPS (Diluted) | -5.07 | -7.57 | -17.90 | -18.02 | -25.67 | 19.52 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | -14.77% | 38.57% | 91.90% | 91.90% | 91.90% | 92.98% |
Operating Margin | -8250.46% | -5936.95% | -6526.44% | -5347.41% | -5059.02% | -4059.33% |
Profit Margin | -8269.53% | -5863.50% | -6092.59% | -5132.57% | -5420.86% | 3507.72% |
EBITDA | -4.45 | -4.27 | -4.7 | - | - | - |
D&A For EBITDA | 0.01 | 0.01 | 0.01 | - | - | - |
EBIT | -4.46 | -4.28 | -4.71 | -3.86 | -3.65 | -2.89 |
Effective Tax Rate | - | - | - | - | - | 0.60% |